文献速递内脏/肾动脉与血管畸形

肾动脉狭窄与动脉瘤的外科血管重建:长期耐久性与生存

Surgical Renovascular Reconstruction for Renal Artery Stenosis and Aneurysm: Long-Term Durability and Survival.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-10-18

这项回顾性单中心研究纳入1993至2007年接受开放手术肾动脉重建的40例患者(31例肾动脉狭窄,9例肾动脉瘤),随访至多20年。结果显示早期死亡率为2.5%,5年生存率88%,再干预3例;作者认为开放手术死亡率低、耐久性良好,仍可考虑作为复杂肾动脉疾病的治疗选择。

要点

  • 开放手术肾动脉重建的早期死亡率为2.5%(40例中1例,为动脉粥样硬化性肾动脉狭窄患者)。
  • 动脉粥样硬化性肾动脉狭窄患者收缩压中位数从术前180 mmHg降至术后1个月155 mmHg(p=.003)和1年160 mmHg(p=.03)。
  • 总体5年生存率为88%,中位随访10.6年;3例因再狭窄再干预(2例腔内、1例开放手术)。

核心结论

  • 开放手术肾动脉重建死亡率低、并发症较少且耐久性良好,作者认为开放手术仍应被视为复杂肾动脉疾病的一种治疗选择。

研究设计与样本

  • 回顾性单中心研究,纳入1993至2007年接受开放手术肾动脉重建的40例患者,登记血压、肾功能、透析依赖、血管通畅性和死亡率,并与人口登记库交叉匹配获得至多20年随访。

主要发现

  • 40例手术患者中25例(63%)为女性;31例因肾动脉狭窄重建,其中23例为动脉粥样硬化性病因、8例为纤维肌性发育不良,另9例为肾动脉瘤。
  • 与纤维肌性发育不良或肾动脉瘤患者相比,动脉粥样硬化性肾动脉狭窄患者年龄更大(p=.008)、外周动脉疾病更广泛(p=.004)、肾功能更差(p=.003)。
  • 纤维肌性发育不良和肾动脉瘤中右肾动脉受累13/17例(76%),而动脉粥样硬化性肾动脉狭窄中病变分布均匀。
  • 动脉粥样硬化性肾动脉狭窄患者中,15/25条(60%)狭窄肾动脉行主-肾动脉旁路术(含2例双侧手术)、2/25条(8%)行髂-肾动脉旁路术、8/25条(32%)行动脉内膜切除术;纤维肌性发育不良中除1例外均行主-肾动脉旁路术。
  • 早期死亡率为2.5%(1例动脉粥样硬化性肾动脉狭窄患者),1例动脉粥样硬化性肾动脉狭窄患者术后需透析。

临床怎么用

  • 作者认为开放手术肾动脉重建仍可考虑作为复杂肾动脉疾病的一种治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study functional outcome, mortality, and dialysis free survival in patients undergoing open primary surgical repair of renal artery stenosis (RAS) or aneurysm (RAA). METHODS: This was a retrospective single centre study of patients undergoing open surgical renal artery reconstruction from 1993 to 2007. Blood pressure, renal function, dialysis dependence, vessel patency, and mortality were registered. Survival was investigated by cross matching with the population registry, yielding up to 20 years of follow up. RESULTS: Of the 40 patients operated on, 25 (63%) were women. RAS was the indication for reconstruction in 31 patients; 23 had atherosclerotic aetiology (ARAS), and eight had fibromuscular dysplasia (FMD). Nine patients had RAA. Patients with ARAS were older (p = .008), had more extensive peripheral arterial disease (p = .004), and inferior renal function (p = .003) compared with patients with FMD or RAA. In FMD and RAA, the right renal artery was affected in 13/17 (76%) cases, whereas in ARAS the disease was evenly distributed. In patients with ARAS, 15/25 (60%) stenotic renal arteries (two bilateral procedures) were managed by aorto-renal bypass, and 2/25 (8%) through ilio-renal bypass. In 8/25 (32%) endarterectomy was performed. In FMD, all but one patient underwent aorto-renal bypass. Early mortality was 2.5% (one patient with ARAS). One patient with ARAS required dialysis post-operatively. Systolic blood pressure was significantly reduced in patients with ARAS, from 180 mmHg (median) pre-operatively to 155 mmHg at one month (p = .003) and 160 mmHg at one year (p = .03). Need for medication decreased from three or more drugs to two drugs at one month (p = .01). In FMD, there was a similar tendency. Three patients underwent re-intervention for restenosis: two endovascularly and one by open surgery. The overall 5 year survival was 88%. Median follow up was 10.6 years. CONCLUSION: Open surgical renal arterial reconstruction was performed with low mortality, fairly low morbidity, and excellent durability. Open surgery should still be considered a therapeutic option in complex renal artery disease.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Steuer J, Bergqvist D, Björck M, et al. Surgical Renovascular Reconstruction for Renal Artery Stenosis and Aneurysm: Long-Term Durability and Survival. Eur J Vasc Endovasc Surg. 2018. PMID: 30343992. doi:10.1016/j.ejvs.2018.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。